| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
8,696 |
7,199 |
$259K |
| 87502 |
|
811 |
741 |
$47K |
| 99214 |
|
669 |
612 |
$30K |
| 87636 |
|
209 |
175 |
$17K |
| 87635 |
|
542 |
451 |
$12K |
| 96372 |
|
2,565 |
2,010 |
$12K |
| 87651 |
|
769 |
685 |
$12K |
| 99203 |
|
183 |
170 |
$8K |
| 99396 |
|
87 |
78 |
$4K |
| 36415 |
|
2,670 |
2,450 |
$4K |
| 81003 |
|
2,285 |
2,010 |
$3K |
| 82962 |
|
1,420 |
1,182 |
$3K |
| 90471 |
|
152 |
144 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
32 |
18 |
$943.97 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
518 |
427 |
$921.11 |
| 99395 |
|
13 |
13 |
$672.58 |
| 86328 |
|
21 |
12 |
$669.38 |
| 86769 |
|
15 |
12 |
$505.50 |
| 92551 |
|
74 |
67 |
$500.17 |
| 90756 |
|
30 |
29 |
$478.59 |
| 87801 |
|
13 |
13 |
$447.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
470 |
429 |
$339.51 |
| 90688 |
|
31 |
31 |
$338.96 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
551 |
428 |
$331.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
95 |
85 |
$164.13 |
| 99406 |
|
52 |
36 |
$143.21 |
| 86308 |
|
25 |
21 |
$86.52 |
| 99173 |
|
75 |
65 |
$43.33 |
| 85018 |
|
67 |
57 |
$28.37 |
| 97803 |
|
201 |
157 |
$28.08 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
110 |
81 |
$6.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
179 |
147 |
$4.79 |
| 97802 |
|
291 |
263 |
$0.00 |
| 36416 |
|
16 |
12 |
$0.00 |